Clinical Trials Browser

Terminated × Interventional × Psoriasis × Clear all

Psoriasis

NCT03656627 2023-02-15

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Arthritis, Rheumatoid, Autoimmune Diseases, Carcinoma, Non-Small-Cell Lung, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Multiple Sclerosis, Polymyalgia Rheumatica, Psoriasis, Giant Cell Arteritis

NCT00924950 2019-04-18

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

Phase 4 Terminated

35 enrolled 3 charts

Sarcoma

Psoriasis, Rhabdomyosarcoma, Alveolar

NCT01163253 2017-06-26

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Terminated

2,867 enrolled 77 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis

NCT02201524 2016-10-05

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Phase 2 Terminated

59 enrolled 18 charts

Lymphoid

Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

NCT00129415 2015-05-22

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Phase 1/2 Terminated

28 enrolled

DermatologicLymphoid

Alopecia, Dermatitis, Atopic, Mycosis Fungoides, Psoriasis, Skin Diseases, Urticaria, Lymphoma, T-Cell, Cutaneous, Striae Distensae

Clinical Trials

TYPP

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions